TITLE

Nonrenal regulation of EPO synthesis

AUTHOR(S)
Weidemann, Alexander; Johnson, Randall S.
PUB. DATE
April 2009
SOURCE
Kidney International;Apr2009, Vol. 75 Issue 7, p682
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Erythropoietin (EPO) is a circulating glycoprotein hormone whose principal function is thought to be red blood cell production. It is a classic example of a hypoxia-inducible gene, and studies of the induction of EPO synthesis by low oxygen led to the discovery of a widespread system of hypoxia-inducible transcription factors. Tissue-specific expression of the EPO gene is tightly controlled, and in the adult organism the kidney produces around 90% of systemic EPO. Before birth, the liver is the main site of EPO production; factors contributing to the liver-to-kidney switch are still elusive, but may provide clues to the tissue-specificity of EPO gene expression. EPO has also been detected in non-erythropoietic tissues such as the brain, where it is suggested to exert local protective effects. Apart from classical ways of regulating renal EPO during hypoxia and anemia, novel pathways have been discovered that demonstrate that other organ systems in the adult might not only be important for the production of EPO but also for modulating the hypoxic EPO response. Knowledge of the molecular bases of these non-renal pathways will eventually help to develop pharmacological strategies to induce endogenous EPO production when the main source, the kidney, is significantly impaired. This review will provide an overview of the molecular aspects of EPO gene regulation by hypoxia-inducible transcription factors and of the tissue-specific regulation of EPO production in adult mammals. Insights into the biology of EPO production in genetically modified animals, with an emphasis on recent advances in the understanding of non-renal EPO regulation, will be discussed.Kidney International (2009) 75, 682–688; doi:10.1038/ki.2008.687; published online 21 January 2009
ACCESSION #
36893238

 

Related Articles

  • A Large Gene Network in Immature Erythroid Cells Is Controlled by the Myeloid and B Cell Transcriptional Regulator PU.1. Wontakal, Sandeep N.; Xingyi Guo; Will, Britta; Shi Minyi; Raha, Debasish; Mahajan, Milind C.; Weissman, Sherman; Snyder, Michael; Steidl, Ulrich; Deyou Zheng; Skoultchi, Arthur I. // PLoS Genetics;Jun2011, Vol. 7 Issue 6, Special section p1 

    PU.1 is a hematopoietic transcription factor that is required for the development of myeloid and B cells. PU.1 is also expressed in erythroid progenitors, where it blocks erythroid differentiation by binding to and inhibiting the main erythroid promoting factor, GATA-1. However, other mechanisms...

  • Erythropoietin. Higgins, Rachel R.; Ben-David, Yaacov // Encyclopedic Reference of Cancer;2001, p301 

    A definition of the term "erythropoietin" is presented. It refers to a small glycoprotein hormone that is essential for the production of red blood cells. It promotes the survival, proliferation and differentiation of erythroid progenitor cells to mature erythrocytes and facilitates hemoglobin...

  • An Assessment of Recombinant Human Erythropoietin Effect on Reticulocyte Production Rate and Lifespan Distribution in Healthy Subjects. Wojciech Krzyzanski // Pharmaceutical Research;Apr2007, Vol. 24 Issue 4, p758 

    AbstractPurpose??An empirical pharmacodynamic model was developed to assess the effect of recombinant human erythropoietin (rHu-EPO) treatment on the reticulocyte production rate and lifespan distribution.Materials and Methods??Single doses of rHu-EPO at levels 20, 40, 60, 90, 120, and 160?kIU...

  • Stat and interferon genes identified by network analysis differentially regulate primitive and definitive erythropoiesis. Greenfest-Allen, Emily; Malik, Jeffrey; Palis, James; Stoeckert Jr, Christian J. // BMC Systems Biology;2013, Vol. 7 Issue 1, p1 

    Background: Hematopoietic ontogeny is characterized by overlapping waves of primitive, fetal definitive, and adult definitive erythroid lineages. Our aim is to identify differences in the transcriptional control of these distinct erythroid cell maturation pathways by inferring and analyzing...

  • Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics. Brand, Marjorie; Ranish, Jeffrey A.; Kummer, Nicolas T.; Hamilton, Joan; Igarashi, Kazuhiko; Francastel, Claire; Chi, Tian H.; Crabtree, Gerald R.; Aebersold, Ruedi; Groudine, Mark // Nature Structural & Molecular Biology;Jan2004, Vol. 11 Issue 1, p73 

    During erythroid differentiation, ß-globin gene expression is regulated by the locus control region (LCR). The transcription factor NF-E2p18/MafK binds within this region and is essential for ß-globin expression in murine erythroleukemia (MEL) cells. Here we use the isotope-coded affinity...

  • Cutting red-cell production. Orkin, Stuart H.; Weiss, Mitchell J. // Nature;9/30/1999, Vol. 401 Issue 6752, p433 

    Discusses the regulation of the production of red blood cells. Reference to the study by DeMaria et al in this issue of 'Nature'; Evidence that activation of death receptors on erythroid cells leads to caspase-induced cleavage of a nuclear regulatory protein called GATA-1, which is crucial for...

  • Altered AKT1 and MAPK1 Gene Expression on Peripheral Blood Mononuclear Cells and Correlation with T-Helper Transcription Factors in Systemic Lupus Erythematosus Patients. Garcia-Rodriguez, Sonia; Callejas-Rubio, Jose-Luis; Ortego-Centeno, Norberto; Zumaquero, Esther; Ríos-Fernandez, Raquel; Arias-Santiago, Salvador; Navarro, Pilar; Sancho, Jaime; Zubiaur, Mercedes // Mediators of Inflammation;2012, Vol. 2012, p1 

    Kinases have been implicated in the immunopathological mechanisms of Systemic Lupus Erythematosus (SLE). v-akt murinethymoma viral-oncogene-homolog 1 (AKT1) and mitogen-activated-protein-kinase 1 (MAPK1) gene expressions in peripheral mononuclear cells from thirteen SLE patients with inactive or...

  • Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5. Eilon, Tali; Barash, Itamar // BMC Genomics;2009, Vol. 10, Special section p1 

    Background: Stat5 is a latent transcription factor that regulates essential growth and survival functions in normal cells. Constitutive activity of Stat5 and the involvement of its C-terminally truncated variant have been implicated in blood cell malignancies and mammary or breast cancer. To...

  • Expression of Immunomodulator Gene mRNA in Co-Culture of Mesenchymal Stromal Cells from the Placenta and Human Mononuclear Blood Cells. Savilova, A.; Chulkina, M.; Veryasov, V.; Gordeeva, M.; Trofimov, D.; Sukhikh, G. // Bulletin of Experimental Biology & Medicine;Feb2015, Vol. 158 Issue 4, p561 

    The expression of mRNA of cytokines and immunoregulatory molecules characterizing the interaction of mesenchymal stromal cells from chorionic villi of postpartum placenta and allogenic mononuclear blood cells was studied during 3-day co-culturing of these cells. The expression of foxp3, il2ra,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics